HomeNewsBusinessEconomyCoronavirus impact | No reason to be tight-fisted, time to boost demand as much as possible: Nobel Laureate Abhijit Banerjee

Coronavirus impact | No reason to be tight-fisted, time to boost demand as much as possible: Nobel Laureate Abhijit Banerjee

In an interview with CNBC-TV18, Nobel Laureate Abhijit Banerjee shared his opinion on the government's initiatives to counter the pandemic and outlined what he thinks needs to be done in an unprecedented crisis like this.

April 01, 2020 / 17:59 IST
Story continues below Advertisement

The government has announced a Rs 1.7 lakh crore program that includes a transfer of Rs 500 to every woman Jan-Dhan account holder, extra grain and free gas cylinders, among other things to tackle the coronavirus pandemic.

In an interview with CNBC-TV18, Nobel Laureate Abhijit Banerjee shared his opinion on the government's initiatives and outlined what needs to be done in an unprecedented and unexpected crisis like this.

Story continues below Advertisement

“It is a package that assumes that the crisis will be over in a couple of weeks. Even for very poor Indians Rs 500 isn’t anything. If the crisis lasts two weeks then that is fine. Some of the media coverage suggests that it is only gathering strength and therefore if there will be much longer and bigger shutdown, then a bigger number will be needed,” he said.

On his take on the government's handling of the issue of migrants, he added, “It is hard to double-guess whether the administrative preparations could have been better. The one thing that the government could have done better is just sending less mixed signals. This idea that shops will be open but no one can go out, the police got confused and there were reports of police shutting down shops by force. There was a lack of clarity in some of the announcements and that could have been avoided."

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show